Skip to main content
Clinical Trials/TCTR20230331003
TCTR20230331003
Recruiting
Phase 4

The study to evaluate the efficacy and safety of Adjustable-depth fractional microneedle bipolar radiofrequency in Treatment of Wrinkle and Facial Contouring

ASTRACO MEDICAL NETWORKS LTD.0 sites28 target enrollmentMarch 31, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
ASTRACO MEDICAL NETWORKS LTD.
Enrollment
28
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2023
End Date
October 24, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ASTRACO MEDICAL NETWORKS LTD.

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 25\-55 years
  • 2\. Both male and Female
  • 3\.mild to moderate skin laxity

Exclusion Criteria

  • 1\. Subjects who are pregnant 2\. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin 3\. Subjects who has dermatits, wound or infection at treatment area 4\. Subjects who allergy to anesthesia cream 5\. Subjects who taken oral or injection contraceptive pills 6\. Subjects who had history of melasma treatment within 6 months before arrived the project 7\. Subjects who had history of laser at treatment area within 6 months before arrived the project 8\. Subjects who had history of keloid or hypertrophic scar 9\. Subjects who had history of psychitic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials